North America Oligonucleotide Synthesis Market

The North America oligonucleotide synthesis market is projected to reach USD 11.34 billion by 2030 from USD 4.77 billion in 2025, at a CAGR of 18.9% during the forecast period. Key drivers for the North America oligonucleotide synthesis market are the robust investments by governments and institutions for genomics, precision medicine, and life sciences. This funding is maintaining sequencing and molecular biology workloads across universities, genome centers, and translational labs. As a result, there is a steady demand for primers, probes, adapters, indexing oligos, and custom DNA/RNA used in PCR and NGS workflows.

The North America oligonucleotide synthesis market is competitive. Prominent players include Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Biogen (US), Alnylam Pharmaceuticals, Inc. (US), and Sarepta Therapeutics, Inc. (US). These companies are adopting strategies such as product developments and business expansions to reinforce their presence and increase their product offerings.

To know about the assumptions considered for the study download the pdf brochure

For instance, in March 2025, Alnylam received extended US FDA approval for AMVUTTRA (Vutrisiran) to treat the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults. This approval will help the firm build on treatment approaches to reduce cardiovascular mortality, hospitalizations, and urgent heart failure visits.

Thermo Fisher Scientific Inc. (US)

Thermo Fisher Scientific Inc. is a prominent competitor in the North America oligonucleotide synthesis market for research use and diagnostic purposes. The company offers a diverse molecular workflow portfolio, wherein custom DNA/RNA oligos, PCR and qPCR reagents, enzymes, and controls can be purchased. It is widely used for primer and probe-based testing, including assay development and routine lab workflows that require consistent lot performance. It benefits from strong growth in the North America oligonucleotide synthesis market due to rising demand for its products in therapeutic applications. Key drivers include manufacturing expansions, a comprehensive product portfolio, and strong brand recognition.

Danaher Corporation (US)

Danaher Corporation holds leading market positions in the North America oligonucleotide synthesis market for research oligonucleotides, primarily through Integrated DNA Technologies (IDT). The company is widely used for the synthesis of custom DNA/RNA oligos and has penetrated deeply into the academic and clinical labs and test developers. Its portfolio supports routine molecular workflows, including qPCR primers and probes that are reordered frequently for infectious disease, oncology, and genetic testing panels. IDT also supplies key oligos for genomics workflows, such as NGS adapters and index primers. These are essential for sequencing library preparation. It is one of the leading companies in the competitive landscape with comprehensive offerings. Rising research and development activities around therapeutic oligos, such as siRNA, ASO, and others, support the company's growth in the market.

Market Ranking

The North America oligonucleotide synthesis market is consolidated. Growth is led by therapeutic demand, where oligonucleotide-based drugs drive the highest value orders. Buyers prioritize GMP capacity, impurity control, sequence accuracy, and strong documentation. Turnaround time and scale-up reliability are also key. Danaher is a leader through IDT, with deep reach in custom oligos, primers/probes, and NGS oligos. Labs values its consistent lots and dependable turnaround. Thermo Fisher is a strong player due to its broad workflow pull-through. It benefits from bundling across PCR/NGS workflows and wide distribution into clinical and research labs. Alnylam, Sarepta, and Biogen drive repeat GMP manufacturing cycles and higher batch values. Their needs push suppliers toward stringent QC, stronger analytics, and capacity reservation models.

Related Reports:

North America Oligonucleotide Synthesis Market by Product [(Drugs (ASO, siRNA), Synthesized Oligos (Product (Primers, Probes)), Type (Custom, Predesigned), Reagents, Equipment), Application (Therapeutic, Research, Diagnostics)] - Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com